WHO ICTRP trial
The role of Intraperitoneal Ropivacaine in Laparoscopic Appendicectomy: A…
ACTRN12614001161617 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12614001161617 |
|---|---|
| Public title | The role of Intraperitoneal Ropivacaine in Laparoscopic Appendicectomy: A prospective, double blinded randomised control study |
| Scientific title | The effect of intraperitoneal Ropivacaine on post-laparoscopic pain in appendicectomy patients compared with the effect of intraperitoneal normal saline. |
| Primary sponsor | Armadale and Kelmscott Memorial Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Appendicitis ;Abdominal pain; Appendicitis Abdominal pain;Surgery - Surgical techniques;Anaesthesiology - Pain management |
| Interventions | Intraperitoneal injection of 0.5ml per kilogram of 0.2% Ropivacaine after the insertion of suprapubic port and another 0.5ml per kilogram of the same solution at the end of laparoscopic appendicectomy. |
| Registration date | Apr 11, 2014 |
| Target size | 128 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: